Previous 10 | Next 10 |
Cardiovascular Systems (CSII): FQ2Revenue of $64.2M (-6.0% Y/Y) misses by $1.31M.Press Release For further details see: Cardiovascular Systems misses on revenue
Conference Call Scheduled for Today, February 3, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $64.2 million increased 6% sequentially compared to first quarter Net loss was $0.1 million, or $0.00 per basic and diluted share Management provides fiscal 2021...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) announced today that it has partnered with Chansu Vascular Technologies, LLC (CVT) to develop novel peripheral and coronary everolimus drug-coated balloons (DCBs). This partnership brings together CSI’s leadership in t...
Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced the addition of independent board member Sachi...
Cardiovascular Systems (CSII) has received CE Mark for its Diamondback 360 Coronary Orbital Atherectomy System ((OAS)) and ViperWire Advance Coronary Guide Wire with Flex Tip. Diamondback combines differential sanding and pulsatile forces to treat all calcium modalities, including n...
One solution to both reduce surface calcium and fracture deep calcium Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and c...
Live Webcast at 3:30 p.m. CT (4:30 p.m. ET) Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will host a live webcast of its fiscal 2021 second-quarter conference call on Wednesday, February 3, 2021, at 3:30 p.m. CT (4:30 p.m. ET). CSI management will discus...
On Wednesday, January 13, 2021, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, will participate in a fireside chat presentation at the 23 rd Annual Needham Virtual Growth Conference at 4:15 p.m. Eastern Time. You may ac...
On Wednesday, November 18, 2020, Cardiovascular Systems’ (NASDAQ: CSII) Chairman, President and Chief Executive Officer, Scott Ward, will present at the Stifel 2020 Virtual Healthcare Conference at 3:20 p.m. Eastern Time. You may access the live audio webcast, as well as a re...
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: Cardiovascular Systems, Inc. 2021 Q1 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
Cardiovascular Systems Inc. Company Name:
CSII Stock Symbol:
NASDAQ Market:
Cardiovascular Systems Inc. Website:
Cytek Biosciences Set to Join S&P SmallCap 600 Cytek Biosciences Set to Join S&P SmallCap 600 PR Newswire NEW YORK , April 25, 2023 /PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P S...
Largest randomized coronary atherectomy trial ever conducted Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today...
NEW YORK, NY / ACCESSWIRE / April 2, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: INDUS Realty Trust, Inc. (NASDAQ:I...